CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor. It has versatile applications for researching pathological diseases such as atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer.
Molekulargewicht:
467.54
Reinheit:
99.88%
CAS Nummer:
[205256-55-9]
Formel:
C23H25N5O4S
Target-Kategorie:
PDGFR
T60226
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten